Related Experiment Videos
Crystal-induced acute renal failure
1Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06520-8029, USA.
The American Journal of Medicine
|May 4, 1999
Summary
Certain medications can form crystals in urine, causing acute kidney injury. Prevention and management involve proper dosing, hydration, and urine alkalinization to protect kidney function.
Area of Science:
- Nephrology
- Pharmacology
- Toxicology
Background:
- Several medications, including acyclovir, sulfonamides, methotrexate, indinavir, and triamterene, are known to precipitate crystals in urine.
- Intratubular crystal deposition can lead to acute renal insufficiency, particularly in patients with risk factors like dehydration or pre-existing kidney disease.
Purpose of the Study:
- To review the mechanisms of drug-induced crystal nephropathy.
- To outline strategies for preventing and managing acute renal failure caused by drug-induced crystals.
Main Methods:
- Literature review of medications associated with crystal formation.
- Analysis of risk factors contributing to drug-induced intrarenal crystal deposition.
- Discussion of preventative and therapeutic interventions.
Main Results:
- Medications like acyclovir and indinavir can cause crystalluria and acute kidney injury.
- Risk factors such as volume depletion and underlying renal insufficiency exacerbate crystal deposition.
- Preventive measures include appropriate drug dosing, hydration, and urine alkalinization.
Conclusions:
- Acute renal failure from drug-induced crystals is often preventable with proactive management.
- Early recognition and intervention, including drug discontinuation and supportive care, can lead to reversible renal failure.
- Management strategies focus on fluid management, urine pH modification, and avoidance of nephrotoxins.